Corrigendum to 'Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study' [The Lancet Regional Health – Europe 41 (2024) 100912]

Autor: Maria Lucia Iacovino, Simone Celant, Luca Tomassini, Laura Arenare, Andrea Caglio, Andrea Canciello, Flavio Salerno, Pier Paolo Olimpieri, Susanna Di Segni, Antonella Sferrazza, Maria Carmela Piccirillo, Giordano Domenico Beretta, Carmine Pinto, Livio Blasi, Saverio Cinieri, Luigi Cavanna, Massimo Di Maio, Pierluigi Russo, Francesco Perrone

Publikováno v: The Lancet Regional Health. Europe, Vol 42, Iss , Pp 100940- (2024)

Externí odkaz: https://doaj.org/article/19d2ce23cfc64059a371543a26def14e

?-Sulfonamido gonadotropin-releasing hormone analogs: synthesis and evaluation of several parent hormone properties

Autor: Nurit Ben-Aroya, Susanna Di-Segni, Shai Rahimipour, Yitzhak Koch, Cesare Giordano, Mati Fridkin

Publikováno v: Journal of peptide science
11 (2005): 45–52. doi:10.1002/psc.596
info:cnr-pdr/source/autori:Di-Segni S.; Giordano C.; Rahimipour S.; Ben-Aroya N.; Koch Y.; Fridkin M./titolo:Beta-sulfonamido gonadotropin-releasing hormone analogs: synthesis and evaluation of several parent hormone properties./doi:10.1002%2Fpsc.596/rivista:Journal of peptide science (Print)/anno:2005/pagina_da:45/pagina_a:52/intervallo_pagine:45–52/volume:11

With the aim of producing long-acting analogs of gonadotropin releasing hormone (GnRH), four analogs, containing -X(6) (aa)psi(CH(2)SO(2)NH)-Leu(7) building unit (X(aa)=Gly, Ala, Val or Phe), and a reduced-size analog [Des-Tyr(5)]-GnRH which includes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa83e8a42647967a1d8b88be7676dfd6
https://doi.org/10.1002/psc.596

Liposomal doxorubicin with and without TNFalpha in the perfusional treatment of advanced soft tissue limb sarcoma: preliminary results

Autor: Franco, Di Filippo, Michele, Anzà, Rosa, Garinei, Francesco, Cavaliere, Pasquale, Perri, Claudio, Botti, Piera, Di Angelo, Simona, Di Filippo, Carlo Ludovico, Maini, Rossella, Pasqualoni, Susanna, Di Segni, Simona, Colantonio, Pietro, Bruno, Loredana, Piarulli, Francesca, Principi

Publikováno v: In vivo (Athens, Greece). 20(6A)

A combination of doxorubicin and tumor necrosis factor alpha (TNFalpha) has been proven to be very effective in the perfusional treatment of advanced soft tissue limb sarcoma both in terms of tumor necrosis and limb conservative surgery rate. Unfortu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5fd90631d5687aba027c6b9415b0a4e9
https://pubmed.ncbi.nlm.nih.gov/17203757

Novel cyclic azo-bridged analogs of gonadotropin-releasing hormone

Autor: Irina Kustanovich, Masha M. Rosenberg, Mati Fridkin, Chaim Gilon, Yitzhak Koch, Susanna Di-Segni, Gil Fridkin, Aviva Kapitkovsky, Shai Rahimipour, Nurit Ben-Aroya

Publikováno v: Journal of peptide science : an official publication of the European Peptide Society. 12(2)

Five linear analogs of GnRH containing a p-aminophenylalanine (Pap) residue in their sequence and their six corresponding azo-bridged cyclic derivatives were synthesized. The precyclic peptides were prepared on solid-support, while azo-cyclization wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6589445e58c508df93e15711010bd5dc
https://pubmed.ncbi.nlm.nih.gov/16059965

Bevacizumab: One Treatment for All the Seasons?

Autor: M. Zeuli, Alain Gelibter, Susanna Di Segni, Francesco Cognetti

Publikováno v: Journal of Clinical Oncology. 26:511-511

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e219fd14e3416e2272916e52b1b4c54d
https://doi.org/10.1200/jco.2007.15.0292